ANI PHARMACEUTICALS INC — Director's Dealing 2013

Jul 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2013-07-12

Reporting Person: Arnold Charlotte C. (Vice President and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-12	Option to Purchase	$1.06	A	266000	Acquired	2023-07-11	Common Stock (266000)	Direct

Footnotes

F1: Option vests over a four year period beginning on the first anniversary of the grant date. This award is contingent upon receipt by the issuer of approval of its stockholders of an amendment to the issuer's 2008 Stock Incentive Plan to increase the number of shares authorized for issuance under the Plan.